FDA approves drug to protect infants from RSV
The FDA approved the drug Beyfortus to protect young children against RSV. If the CDC agrees with the FDA’s recommendations, the injections could be available by the fall. NBC News’ Tom Costello has details.
NBC News LogoPoliticsU.S. NewsWorldBusinessTechHealthCulture & trendsNBC News Tipline
My NewsManage ProfileEmail PreferencesSign OutSearchSearchProfile
My NewsSign Out Sign InCreate your free profileSections
tv
Featured
Post ID: d1d1d4c9-45db-4dc3-afd4-9b7321364c78
Rating: 5
Rating: 5
Created: 1 year ago